Natco Pharma Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting
14-08-2026 | 02:12 pm
14-08-2026 | 02:12 pm
NATCO Pharma board approved Q1FY27 consolidated results: revenue ₹794.4 Cr, net profit ₹206.5 Cr. Declared ₹1.50/share interim dividend. Also exploring fundraising up to ₹2000 Cr. #NATCOPHARM
No comments yet. Be the first to comment!
